Patricia Richi

TL;DR: PDUS is a sensitive and reliable method for longitudinal assessment of inflammatory activity in early rheumatoid arthritis and may have a predictive value in disease activity and radiographic outcome.

TL;DR: In patients on biological therapy, a high rate of HBV vaccine response can be achieved when a complete vaccination schedule is administered, which supports the proposal already made to provide HBV vaccination to all patients with an autoimmune inflammatory disease after the diagnosis is made and not when the use of a biological treatment is under consideration.

TL;DR: In this paper, the authors provided a prioritised list of research questions and the eligible spectrum of inflammatory arthritis, biologic drugs and infectious disease were defined in order to perform a systematic literature review.

TL;DR: The results suggest that radiofrequency-based measurement of CCA-IMT can discriminate between RA patients treated with synthetic DMARDs vs RA patientstreated with synthetic and biologic DMARDS.

TL;DR: In this article, the pneumococcal vaccines PCV13 and PPV23 were combined to achieve OPKA titers against a larger number of serotypes than the rest of patients on other biological therapies such as anti-TNFα, rituximab, tocilizumab, abatacept or anakinra.